Breaking News

Press Releases

Rigenerand: “Lottiamo contro il cancro” – Il Resto del Carlino 26/02/2019

Press Releases

Il Resto del Carlino – 16/02/2019

Press Releases

Rigenerand Gene Therapy Key Technology Published in Scientific Journals

Press Releases

Rigenerand Announces Orphan Drug Designations from both EMA and FDA Obtained by RR001 for the Treatment of Pancreatic Cancer

Rigenerand srl announces the positive opinion on orphan drug designation (ODD) issued by the European Medicines Agency (EMA) for RR001, for the treatment of pancreatic cancer. This relevant milestone immediately follows the ODD granted by the FDA (USA) on May 2018 for the same indication.

Press Releases,vitvo

Rigenerand is presenting VITVO at the AACR meeting in Chicago on April, 14/18 2018

Visit us at booth 4207 and explore the VITVO® infinite possibilities of culturing in the 3D dimension.

Press Releases

Rigenerand brings novelty at the 3D Tissue Models Oncology Congress in Boston on May, 8/10 2018

Rigenerand shares data on its novel 3D culture system during the 3D Tissue Models Oncology Congress in Boston.